Description:(+)-JQ1basedPROTACthatselectivelydegradesBRD4incells
ChemicalName:(6S)-4-(4-Chlorophenyl)-N-[4-[[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetyl]amino]butyl]-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide
Purity:≥98%(HPLC)
BIOLOGicalActivityTechnicalDataSolubilityCalculatorsDatasheetsReferences
BiologicalActivity
PROTACcomprisingBETantagoNIST(+)-JQ1(Cat.No.4499)conjugatedtoacereblonE3ubiquitinligaseligand.DepletesBRD4incancercelllinesinvitro(EC50=430nMinbreastcancercells)andinducesapoptosis.DelaystumorgrowthanddownregulatesMYCinmicebearinghumanAMLxenografts.
LicensingInformation
SoldunderlicensefromDana-FarberCancerInstitute.
TechnicalData
| M.Wt | 785.27 |
| Formula | C38H37ClN8O7S |
| Storage | Storeat-20°C |
| Purity | ≥98%(HPLC) |
| CASNumber | 1799711-21-9 |
| PubChemID | 91799313 |
| InChIKey | LKEGXJXRNBALBV-PMCHYTPCSA-N |
| Smiles | CC1=NN=C2[C@@H](N=C(C3=CC=C(C=C3)Cl)C4=C(N12)SC(C)=C4C)CC(NCCCCNC(COC5=C6C(N(C(C6=CC=C5)=O)C7CCC(NC7=O)=O)=O)=O)=O |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
SolubilityData
| Solvent | MaxConc.mg/mL | MaxConc.mM |
|---|
| Solubility |
|---|
| DMSO | 78.53 | 100 |
PreparingStockSolutions
Thefollowingdataisbasedontheproductmolecularweight785.27.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
| Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
|---|
| 1mM | 1.27mL | 6.37mL | 12.73mL |
| 5mM | 0.25mL | 1.27mL | 2.55mL |
| 10mM | 0.13mL | 0.64mL | 1.27mL |
| 50mM | 0.03mL | 0.13mL | 0.25mL |
购物车为空，快去购物吧！
4000-520-616
咨询顾问